Kilitch Drugs (India) Limited (KILITCH.BO)

INR 341.85

(-2.37%)

Operating Expenses Summary of Kilitch Drugs (India) Limited

  • Kilitch Drugs (India) Limited's latest annual operating expenses in 2023 was 412.42 Million INR , down -12.94% from previous year.
  • Kilitch Drugs (India) Limited's latest quarterly operating expenses in 2024 Q1 was 105.52 Million INR , down -0.58% from previous quarter.
  • Kilitch Drugs (India) Limited reported a annual operating expenses of 473.72 Million INR in annual operating expenses 2022, up 35.57% from previous year.
  • Kilitch Drugs (India) Limited reported a annual operating expenses of 349.42 Million INR in annual operating expenses 2021, up 33.08% from previous year.
  • Kilitch Drugs (India) Limited reported a quarterly operating expenses of 106.13 Million INR for 2023 Q4, up 5.94% from previous quarter.
  • Kilitch Drugs (India) Limited reported a quarterly operating expenses of 141.56 Million INR for 2023 Q1, up 26.62% from previous quarter.

Annual Operating Expenses Chart of Kilitch Drugs (India) Limited (2023 - 2006)

Historical Annual Operating Expenses of Kilitch Drugs (India) Limited (2023 - 2006)

Year Operating Expenses Operating Expenses Growth
2023 412.42 Million INR -12.94%
2022 473.72 Million INR 35.57%
2021 349.42 Million INR 33.08%
2020 262.56 Million INR 25.85%
2019 208.62 Million INR -7.55%
2018 225.66 Million INR 32.04%
2017 170.9 Million INR -32.97%
2016 254.96 Million INR 7.34%
2015 237.51 Million INR 74.75%
2014 135.91 Million INR 5.78%
2013 128.48 Million INR 29.11%
2012 99.52 Million INR -64.91%
2011 283.58 Million INR -2.6%
2010 291.13 Million INR 106.43%
2009 141.03 Million INR -16.56%
2008 169.03 Million INR 11.23%
2007 151.96 Million INR 144.57%
2006 62.13 Million INR 0.0%

Peer Operating Expenses Comparison of Kilitch Drugs (India) Limited

Name Operating Expenses Operating Expenses Difference
Alembic Pharmaceuticals Limited 15.86 Billion INR 97.401%
Aurobindo Pharma Limited 39.23 Billion INR 98.949%
Glenmark Life Sciences Limited 11.64 Billion INR 96.457%
Granules India Limited 7.18 Billion INR 94.258%
Indoco Remedies Limited 4.74 Billion INR 91.315%
Achyut Healthcare Limited 1.6 Million INR -25532.505%
Ajanta Pharma Limited 30.46 Billion INR 98.646%
Alkem Laboratories Limited 32.83 Billion INR 98.744%
Alpa Laboratories Limited 156.14 Million INR -164.127%
Brooks Laboratories Limited 51.18 Million INR -705.836%
AstraZeneca Pharma India Limited 2.6 Billion INR 84.14%
Bajaj HealthCare Limited 985.34 Million INR 58.144%
Bliss GVS Pharma Limited 1.41 Billion INR 70.94%
Dr. Reddy's Laboratories Limited 95.87 Billion INR 99.57%
Eris Lifesciences Limited 4.94 Billion INR 91.656%
FDC Limited 5.34 Billion INR 92.289%
Glenmark Pharmaceuticals Limited 67.56 Billion INR 99.39%
Gufic Biosciences Limited 1.07 Billion INR 61.731%
Ind-Swift Laboratories Limited 2.12 Billion INR 80.584%
Ipca Laboratories Limited 13.91 Billion INR 97.036%
Jagsonpal Pharmaceuticals Limited 773.41 Million INR 46.674%
Krebs Biochemicals & Industries Limited 46.15 Million INR -793.55%
Lasa Supergenerics Limited 291.17 Million INR -41.643%
Laurus Labs Limited 3.01 Billion INR 86.302%
Lupin Limited 95.67 Billion INR 99.569%
Mankind Pharma Limited 23.15 Billion INR 98.219%
Medicamen Biotech Limited 335.16 Million INR -23.051%
Medico Remedies Limited 161.84 Million INR -154.83%
Megasoft Limited 49.52 Million INR -732.715%
NATCO Pharma Limited 10.05 Billion INR 95.9%
Piramal Pharma Limited 19.91 Billion INR 97.929%
RPG Life Sciences Limited 1.63 Billion INR 74.783%
Sigachi Industries Limited 579.88 Million INR 28.878%
Sun Pharmaceutical Industries Limited 154.18 Billion INR 99.733%
Suven Pharmaceuticals Limited 1.4 Billion INR 70.599%
Syncom Formulations (India) Limited 942.39 Million INR 56.236%
Unichem Laboratories Limited 6.72 Billion INR 93.868%
Wanbury Limited 1.16 Billion INR 64.474%
Windlas Biotech Limited 1 Billion INR 59.024%
ZIM Laboratories Limited 1.01 Billion INR 59.289%
Zydus Lifesciences Limited 43.17 Billion INR 99.045%
Sun Pharma Advanced Research Company Limited 3.07 Billion INR 86.596%
Divi's Laboratories Limited 14.17 Billion INR 97.089%
Hester Biosciences Limited 908.84 Million INR 54.621%
Procter & Gamble Health Limited 2.99 Billion INR 86.231%
Amrutanjan Health Care Limited 1.09 Billion INR 62.472%
Bal Pharma Limited 389.89 Million INR -5.78%
Strides Pharma Science Limited 9.16 Billion INR 95.499%
Venus Remedies Limited 1.91 Billion INR 78.478%
Aarti Pharmalabs Limited 3.07 Billion INR 86.585%
Nectar Lifesciences Limited 625.55 Million INR 34.07%
Shilpa Medicare Limited 2.18 Billion INR 81.086%
Aarti Drugs Limited 1.16 Billion INR 64.674%
IOL Chemicals and Pharmaceuticals Limited 1.09 Billion INR 62.466%
Suven Life Sciences Limited 109.75 Million INR -275.788%
Ind-Swift Limited 946.56 Million INR 56.429%
Valiant Laboratories Limited 36.28 Million INR -1036.507%
J. B. Chemicals & Pharmaceuticals Limited 8.41 Billion INR 95.1%
Solara Active Pharma Sciences Limited 4.57 Billion INR 90.994%
Themis Medicare Limited 782.85 Million INR 47.318%
Hikal Limited 2.48 Billion INR 83.412%
Torrent Pharmaceuticals Limited 21.42 Billion INR 98.075%
Sequent Scientific Limited 2.9 Billion INR 85.787%
Novartis India Limited 470.1 Million INR 12.268%
Wockhardt Limited 6.4 Billion INR 93.556%
Jubilant Pharmova Limited 14.45 Billion INR 97.147%
Biofil Chemicals and Pharmaceuticals Limited 16.2 Million INR -2444.322%
Neuland Laboratories Limited 2.92 Billion INR 85.923%
Morepen Laboratories Limited 1.98 Billion INR 79.248%
Mangalam Drugs & Organics Limited 676.14 Million INR 39.003%